# Guidewire Software, Inc.: financial statements, quarterly

GWRE · NYSE · CIK 1528396 · [Technology](/sectors/technology.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/gwre.md) · [Financials](/companies/gwre/financials.md) · [Filings](/companies/gwre/filings.md) · [Insiders](/companies/gwre/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gwre/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [207](/filings/0001528396-24-000162.md) | [241](/filings/0001528396-25-000061.md) | [241](/filings/0001528396-25-000137.md) | [292 d](/filings/0001528396-26-000046.md) | [263](/filings/0001528396-25-000244.md) | [289](/filings/0001528396-26-000014.md) | [294](/filings/0001528396-26-000027.md) | [357 d](/filings/0001528396-26-000046.md) | [333](/filings/0001528396-25-000244.md) | [359](/filings/0001528396-26-000014.md) | [373](/filings/0001528396-26-000027.md) | [411 d](/filings/0001528396-26-000046.md) |
| Cost of revenue | $m | [95.1](/filings/0001528396-24-000162.md) | [98.5](/filings/0001528396-25-000061.md) | [98.5](/filings/0001528396-25-000137.md) | [105 d](/filings/0001528396-26-000046.md) | [105](/filings/0001528396-25-000244.md) | [110](/filings/0001528396-26-000014.md) | [111](/filings/0001528396-26-000027.md) | [125 d](/filings/0001528396-26-000046.md) | [123](/filings/0001528396-25-000244.md) | [128](/filings/0001528396-26-000014.md) | [136](/filings/0001528396-26-000027.md) | [141 d](/filings/0001528396-26-000046.md) |
| Gross profit | $m | [112](/filings/0001528396-24-000162.md) | [142](/filings/0001528396-25-000061.md) | [142](/filings/0001528396-25-000137.md) | [186 d](/filings/0001528396-26-000046.md) | [158](/filings/0001528396-25-000244.md) | [179](/filings/0001528396-26-000014.md) | [183](/filings/0001528396-26-000027.md) | [232 d](/filings/0001528396-26-000046.md) | [210](/filings/0001528396-25-000244.md) | [232](/filings/0001528396-26-000014.md) | [237](/filings/0001528396-26-000027.md) | [270 d](/filings/0001528396-26-000046.md) |
| Research and development | $m | [62.5](/filings/0001528396-24-000162.md) | [65.5](/filings/0001528396-25-000061.md) | [66.1](/filings/0001528396-25-000137.md) | [75.3 d](/filings/0001528396-26-000046.md) | [68.9](/filings/0001528396-25-000244.md) | [70.3](/filings/0001528396-26-000014.md) | [72.9](/filings/0001528396-26-000027.md) | [84.1 d](/filings/0001528396-26-000046.md) | [78.3](/filings/0001528396-25-000244.md) | [83.3](/filings/0001528396-26-000014.md) | [87.9](/filings/0001528396-26-000027.md) | [90.6 d](/filings/0001528396-26-000046.md) |
| Operating income | $m | [(33.8)](/filings/0001528396-24-000162.md) | [(12.4)](/filings/0001528396-25-000061.md) | [(16.7)](/filings/0001528396-25-000137.md) | [10.3 d](/filings/0001528396-26-000046.md) | [(4.7)](/filings/0001528396-25-000244.md) | [11.7](/filings/0001528396-26-000014.md) | [4.5](/filings/0001528396-26-000027.md) | [29.6 d](/filings/0001528396-26-000046.md) | [18.5](/filings/0001528396-25-000244.md) | [38.4](/filings/0001528396-26-000014.md) | [30.6](/filings/0001528396-26-000027.md) | [62.3 d](/filings/0001528396-26-000046.md) |
| Interest expense | $m | [1.7](/filings/0001528396-23-000137.md) | [1.7](/filings/0001528396-24-000017.md) | [1.7](/filings/0001528396-24-000057.md) | [1.7 d](/filings/0001528396-26-000046.md) | [2.1](/filings/0001528396-25-000244.md) | [4.2](/filings/0001528396-26-000014.md) | [3.7](/filings/0001528396-26-000027.md) | [3.3 d](/filings/0001528396-26-000046.md) | [3.3](/filings/0001528396-25-000244.md) | [3.3](/filings/0001528396-26-000014.md) | [3.3](/filings/0001528396-26-000027.md) | [3.4 d](/filings/0001528396-26-000046.md) |
| Income tax | $m | [(11.5)](/filings/0001528396-24-000162.md) | [(2.7)](/filings/0001528396-25-000061.md) | [(8.6)](/filings/0001528396-25-000137.md) | [2.1 d](/filings/0001528396-26-000046.md) | [(6.4)](/filings/0001528396-25-000244.md) | [(5.8)](/filings/0001528396-26-000014.md) | [2.7](/filings/0001528396-26-000027.md) | [(11.0) d](/filings/0001528396-26-000046.md) | [(6.8)](/filings/0001528396-25-000244.md) | [14.4](/filings/0001528396-26-000014.md) | [3.3](/filings/0001528396-26-000027.md) | [13.9 d](/filings/0001528396-26-000046.md) |
| Net income | $m | [(27.1)](/filings/0001528396-25-000137.md) | [9.7](/filings/0001528396-25-000137.md) | [(5.5)](/filings/0001528396-25-000137.md) | [(6.1)](/filings/0001528396-26-000046.md) | [9.1](/filings/0001528396-26-000027.md) | [(37.3)](/filings/0001528396-26-000027.md) | [46.0](/filings/0001528396-26-000027.md) | [52.0 d](/filings/0001528396-26-000046.md) | [31.3](/filings/0001528396-26-000027.md) | [60.1](/filings/0001528396-26-000027.md) | [16.5](/filings/0001528396-26-000027.md) | [31.4 d](/filings/0001528396-26-000046.md) |
| Diluted EPS | $ per share | [(0.33)](/filings/0001528396-24-000162.md) | [0.12](/filings/0001528396-25-000061.md) | [(0.07)](/filings/0001528396-25-000137.md) | not reported | [0.11](/filings/0001528396-25-000244.md) | [(0.45)](/filings/0001528396-26-000014.md) | [0.54](/filings/0001528396-26-000027.md) | not reported | [0.36](/filings/0001528396-25-000244.md) | [0.70](/filings/0001528396-26-000014.md) | [0.19](/filings/0001528396-26-000027.md) | not reported |
| Basic EPS | $ per share | [(0.33)](/filings/0001528396-24-000162.md) | [0.12](/filings/0001528396-25-000061.md) | [(0.07)](/filings/0001528396-25-000137.md) | not reported | [0.11](/filings/0001528396-25-000244.md) | [(0.45)](/filings/0001528396-26-000014.md) | [0.55](/filings/0001528396-26-000027.md) | not reported | [0.37](/filings/0001528396-25-000244.md) | [0.71](/filings/0001528396-26-000014.md) | [0.20](/filings/0001528396-26-000027.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [301](/filings/0001528396-23-000137.md) | [350](/filings/0001528396-24-000017.md) | [360](/filings/0001528396-24-000057.md) | [548](/filings/0001528396-25-000221.md) | [824](/filings/0001528396-24-000162.md) | [697](/filings/0001528396-25-000061.md) | [510](/filings/0001528396-25-000137.md) | [698](/filings/0001528396-26-000046.md) | [492](/filings/0001528396-25-000244.md) | [408](/filings/0001528396-26-000014.md) | [295](/filings/0001528396-26-000027.md) | [373](/filings/0001528396-26-000046.md) |
| Current assets | $m | [977](/filings/0001528396-23-000137.md) | [1,061](/filings/0001528396-24-000017.md) | [1,082](/filings/0001528396-24-000057.md) | [1,296](/filings/0001528396-25-000221.md) | [1,637](/filings/0001528396-24-000162.md) | [1,478](/filings/0001528396-25-000061.md) | [1,313](/filings/0001528396-25-000137.md) | [1,507](/filings/0001528396-26-000046.md) | [1,357](/filings/0001528396-25-000244.md) | [1,346](/filings/0001528396-26-000014.md) | [1,215](/filings/0001528396-26-000027.md) | [1,187](/filings/0001528396-26-000046.md) |
| Total assets | $m | [1,920](/filings/0001528396-23-000137.md) | [2,014](/filings/0001528396-24-000017.md) | [2,040](/filings/0001528396-24-000057.md) | [2,226](/filings/0001528396-25-000221.md) | [2,597](/filings/0001528396-24-000162.md) | [2,543](/filings/0001528396-25-000061.md) | [2,488](/filings/0001528396-25-000137.md) | [2,721](/filings/0001528396-26-000046.md) | [2,639](/filings/0001528396-25-000244.md) | [2,692](/filings/0001528396-26-000014.md) | [2,535](/filings/0001528396-26-000027.md) | [2,577](/filings/0001528396-26-000046.md) |
| Current liabilities | $m | [262](/filings/0001528396-23-000137.md) | [307](/filings/0001528396-24-000017.md) | [705](/filings/0001528396-24-000057.md) | [838](/filings/0001528396-25-000221.md) | [615](/filings/0001528396-24-000162.md) | [559](/filings/0001528396-25-000061.md) | [406](/filings/0001528396-25-000137.md) | [545](/filings/0001528396-26-000046.md) | [390](/filings/0001528396-25-000244.md) | [459](/filings/0001528396-26-000014.md) | [497](/filings/0001528396-26-000027.md) | [664](/filings/0001528396-26-000046.md) |
| Total liabilities | $m | [714](/filings/0001528396-23-000137.md) | [757](/filings/0001528396-24-000017.md) | [755](/filings/0001528396-24-000057.md) | [884](/filings/0001528396-25-000221.md) | [1,329](/filings/0001528396-24-000162.md) | [1,274](/filings/0001528396-25-000061.md) | [1,125](/filings/0001528396-25-000137.md) | [1,264](/filings/0001528396-26-000046.md) | [1,106](/filings/0001528396-25-000244.md) | [1,181](/filings/0001528396-26-000014.md) | [1,218](/filings/0001528396-26-000027.md) | [1,383](/filings/0001528396-26-000046.md) |
| Long-term debt | $m | not reported | not reported | not reported | [399](/filings/0001528396-24-000105.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,206](/filings/0001528396-25-000137.md) | [1,256](/filings/0001528396-25-000137.md) | [1,285](/filings/0001528396-25-000137.md) | [1,343](/filings/0001528396-26-000046.md) | [1,268](/filings/0001528396-26-000027.md) | [1,269](/filings/0001528396-26-000027.md) | [1,363](/filings/0001528396-26-000027.md) | [1,457](/filings/0001528396-26-000046.md) | [1,533](/filings/0001528396-26-000027.md) | [1,511](/filings/0001528396-26-000027.md) | [1,317](/filings/0001528396-26-000027.md) | [1,194](/filings/0001528396-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(72.1)](/filings/0001528396-24-000162.md) | [69.3 d](/filings/0001528396-25-000061.md) | [4.8 d](/filings/0001528396-25-000137.md) | [194 d](/filings/0001528396-26-000046.md) | [(62.3)](/filings/0001528396-25-000244.md) | [86.0 d](/filings/0001528396-26-000014.md) | [32.4 d](/filings/0001528396-26-000027.md) | [245 d](/filings/0001528396-26-000046.md) | [(67.4)](/filings/0001528396-25-000244.md) | [112 d](/filings/0001528396-26-000014.md) | [61.2 d](/filings/0001528396-26-000027.md) | [284 d](/filings/0001528396-26-000046.md) |
| Capital expenditure | $m | [1.0](/filings/0001528396-24-000162.md) | [3.0 d](/filings/0001528396-25-000061.md) | [0.7 d](/filings/0001528396-25-000137.md) | [1.7 d](/filings/0001528396-26-000046.md) | [0.8](/filings/0001528396-25-000244.md) | [0.8 d](/filings/0001528396-26-000014.md) | [0.7 d](/filings/0001528396-26-000027.md) | [3.4 d](/filings/0001528396-26-000046.md) | [4.9](/filings/0001528396-25-000244.md) | [3.3 d](/filings/0001528396-26-000014.md) | [1.8 d](/filings/0001528396-26-000027.md) | [2.1 d](/filings/0001528396-26-000046.md) |
| Share repurchases | $m | [0.0](/filings/0001528396-23-000137.md) | [0.0 d](/filings/0001528396-24-000017.md) | [0.0 d](/filings/0001528396-24-000057.md) | [0.0 d](/filings/0001528396-26-000046.md) | not reported | not reported | [0.0 d](/filings/0001528396-26-000027.md) | [0.0 d](/filings/0001528396-26-000046.md) | not reported | not reported | [244 d](/filings/0001528396-26-000027.md) | [214 d](/filings/0001528396-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-31) | Q2 FY2023 (2023-01-31) | Q3 FY2023 (2023-04-30) | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [83.3](/filings/0001528396-23-000137.md) | [82.1](/filings/0001528396-24-000017.md) | [81.8](/filings/0001528396-24-000057.md) | [81.7](/filings/0001528396-24-000162.md) | [83.3](/filings/0001528396-25-000061.md) | [82.5](/filings/0001528396-25-000137.md) | [86.0](/filings/0001528396-25-000244.md) | [83.7](/filings/0001528396-26-000014.md) | [85.9](/filings/0001528396-26-000027.md) | [86.5](/filings/0001528396-25-000244.md) | [86.1](/filings/0001528396-26-000014.md) | [85.1](/filings/0001528396-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 81,992,669 at 2026-08-31, from the cover of the [10-K filed 2026-09-11](/filings/0001528396-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.